VIVO
Meridian Bioscience Inc
Price:  
33.97 
USD
Volume:  
2,039,919.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

VIVO WACC - Weighted Average Cost of Capital

The WACC of Meridian Bioscience Inc (VIVO) is 7.3%.

The Cost of Equity of Meridian Bioscience Inc (VIVO) is 7.40%.
The Cost of Debt of Meridian Bioscience Inc (VIVO) is 4.30%.

Range Selected
Cost of equity 6.20% - 8.60% 7.40%
Tax rate 22.00% - 22.40% 22.20%
Cost of debt 4.00% - 4.60% 4.30%
WACC 6.1% - 8.5% 7.3%
WACC

VIVO WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.5 0.66
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.20% 8.60%
Tax rate 22.00% 22.40%
Debt/Equity ratio 0.02 0.02
Cost of debt 4.00% 4.60%
After-tax WACC 6.1% 8.5%
Selected WACC 7.3%